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Abstract
Background: Down syndrome (DS), the most common genetic cause of
intellectual disability, is associated with an ultra-high risk of developing
Alzheimer’s disease. However, there is individual variability in the onset of
clinical dementia and in baseline cognitive abilities prior to decline, particularly
in memory, executive functioning, and motor coordination. The LonDownS
Consortium aims to determine risk and protective factors for the development
of dementia and factors relating to cognitive abilities in people with DS. Here
we describe our cognitive test battery and related informant measures along
with reporting data from our baseline cognitive and informant assessments.
Methods: We developed a cognitive test battery to assess general abilities,
memory, executive function, and motor coordination abilities in adults with DS,
with informant ratings of similar domains also collected, designed to allow for
data on a broad range of participants. Participants (n=305) had a range of ages
and abilities, and included adults with and without a clinical diagnosis of
dementia.
Results: Results suggest the battery is suitable for the majority of adults with
DS, although approximately half the adults with dementia were unable to
undertake any cognitive task. Many test outcomes showed a range of scores
with low floor and ceiling effects. Non-verbal age-adjusted IQ scores had lower
floor effects than verbal IQ scores. Before the onset of any cognitive decline,
females aged 16-35 showed better verbal abilities compared to males. We also
identified clusters of cognitive test scores within our battery related to
visuospatial memory, motor coordination, language abilities, and processing
speed / sustained attention.
Conclusions: Our further studies will use baseline and longitudinal
assessments to explore factors influencing cognitive abilities and cognitive
decline related to ageing and onset of dementia in adults with DS.
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Introduction
Down syndrome (DS) is the most common genetic cause of intel-
lectual disability (ID) and is caused by the presence of an addi-
tional chromosome 21. DS has a UK incidence of approximately 
1 in 1000 live births (Wu & Morris, 2013). The life expectancy 
for individuals with DS has risen dramatically over the previous 
50 years; a recent study estimated current life expectancy to 
be almost 60 (Englund et al., 2013). With this increase in life 
expectancy it has become apparent DS is associated with an ultra- 
high risk of developing Alzheimer’s disease (AD) compared to 
typically developing individuals (Wiseman et al., 2015). A recent 
study estimated lifetime risk for dementia based on cumulative 
incidence may be as high as 95.7% by age 68, with an age-related 
increase from 26.1% at age 50 (McCarron et al., 2014).
This increased risk of dementia is thought to be largely due to the 
overexpression of genes on chromosome 21. Of particular interest 
is the amyloid precursor protein (APP) gene, mutations in which 
have been associated with early onset AD in the typically develop-
ing population. Deposits of amyloid, a characteristic feature of AD 
and encoded by the APP gene, are reported to be present in the 
brains of almost all adults with DS with full trisomy 21 over the age 
of 30 (Mann, 1988; Wisniewski et al., 1985). Despite this, there is 
considerable variability in the clinical presentation and age of onset 
of dementia in DS; some adults receive a dementia diagnosis before 
age 40 while others do not show signs of dementia until they reach 
their 60s, with a mean age of diagnosis of 55 (Coppus et al., 2006; 
Holland et al., 1998; Margallo-Lana et al., 2007; McCarron et al., 
2014; Tyrrell et al., 2001). This wide variability suggests there are 
a number of risk factors for the development of clinical demen-
tia in addition to APP overexpression, as well as protective factors 
against its development.
Dementia in DS develops on a background of an altered cognitive 
profile. Later developing brain networks, including the prefron-
tal cortex (PFC), hippocampus, and cerebellum, have been sug-
gested to be most affected in DS (Edgin, 2013). Structural MRI 
studies have reported smaller brain volumes in these regions in DS 
before the onset of AD (Aylward et al., 1999; Beacher et al., 2010; 
Carducci et al., 2013; Pinter et al., 2001a; Pinter et al., 2001b; 
Teipel et al., 2003), and delayed hippocampal myelination has 
been demonstrated (Ábráham et al., 2012). In addition, altered 
frontal functional connectivity (Anderson et al., 2013; Pujol et al., 
2015) and white matter integrity (Powell et al., 2014) have been 
reported in DS. Those with dementia show further reduction in 
hippocampal volumes (Aylward et al., 1999; Beacher et al., 2009) 
and decreased frontal white matter integrity (Powell et al., 2014) 
compared to those without dementia.
Altered development of the PFC, hippocampus and cerebellum 
in DS is supported by studies reporting related cognitive impair-
ments, specifically in executive function, memory and motor coor-
dination respectively. Individuals with DS show impaired executive 
functioning abilities compared to both mental age (MA) matched 
typically developing controls and individuals with non-DS ID 
(Lanfranchi et al., 2010; Rowe et al., 2006), although one aspect 
of executive functioning, working memory, has been reported not 
to be affected in DS compared to MA controls (Pennington et al., 
2003). Both verbal and visuospatial memory have been reported 
to be impaired in DS compared to MA controls (Pennington et al., 
2003), in particular as memory load increases (Visu-Petra et al., 
2007). It has further been suggested individuals with DS show rela-
tively poorer verbal compared to visuospatial memory (Baddeley 
& Jarrold, 2007; Jarrold et al., 2002; Lanfranchi et al., 2012), and 
visual object memory is more impaired than visual spatial mem-
ory (Vicari et al., 2005). Finally, individuals with DS have been 
reported to show slower motor responses compared to MA controls 
(Edgin et al., 2010; Frith & Frith, 1974). Although these general 
profiles of cognitive abilities are found for individuals with DS at 
the group level, there is a large variability both across and within 
individuals in cognitive profiles.
This cognitive profile in DS has been proposed to affect the 
presentation of dementia symptoms. Decline in frontal function 
(Holland et al., 1998; Holland et al., 2000), characterised by 
executive function impairments (Adams & Oliver, 2010; Ball 
et al., 2008) and behavioural and personality changes (Ball et al., 
2006; Dekker et al., 2015), has been implicated as an early 
dementia-related change in DS. Memory impairments, usually 
associated with AD in the general population, are also found in 
adults with DS and dementia (Ball et al., 2006; Kittler et al., 2006), 
with changes in praxis occurring later (Dalton et al., 1999).
Concept and aims
The London Down Syndrome Consortium (LonDownS) aims to 
identify risk and protective factors for the development of the clini-
cal signs of dementia in DS. This will inform understanding of the 
development of AD and identify potential mechanisms as well as 
predictive phenotypes. We also aim to establish the pre-dementia 
cognitive profile of adults with DS, allowing us to identify factors 
relating to cognitive abilities. This will help to inform interventions 
to influence developmental trajectories across the lifespan.
Our study therefore requires detailed cognitive assessments that 
allow for data on the broadest range of participants possible in 
terms of age and abilities, with minimal floor and ceiling effects. 
We also took into account the typical cognitive difficulties in this 
population, such as expressive language impairment, as well as 
co-morbidities such as hearing and vision problems. We therefore 
compiled a cognitive assessment battery requiring minimal verbal 
responses and using informant ratings of similar domains.
Here, we describe the LonDownS cognitive test battery for adults 
with DS, and provide data on baseline cognitive and related inform-
ant assessments.
Methods
Participants
Cohort 1: adults aged 36 years and over. We have recruited and 
completed baseline assessments for 181 adults aged 36 years and 
over, with (n=51) and without (n=130) a clinical diagnosis of 
dementia, with longitudinal assessments planned to assess cogni-
tive decline. Longitudinal assessments are essential to assess cog-
nitive decline in individuals with DS due to the presence of an ID 
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potentially confounding test results. Two additional adults were 
assessed then excluded from analyses after genetic testing revealed 
no additional chromosome 21, mosaicism or translocation. One 
further adult withdrew after starting the initial assessment.
Cohort 2: adults aged 16–35 years. We have recruited and assessed 
124 adults aged 16–35 years. These adults have initially been 
assessed once, to explore cross-sectional cognitive profiles of 
individuals with DS before the onset of dementia.
Recruitment. Participants were recruited across England and Wales 
(focusing on the Greater London area and South East England) via 
local care homes, DS support groups and existing participant data-
bases. We also established a network of National Health Service 
(NHS) Trust sites to identify and approach potential participants. 
Participants were given a gift voucher as compensation for their 
time, and we reimbursed all travel expenses.
Inclusion and exclusion criteria. All participants were required 
to have a clinical diagnosis of DS. This was confirmed genetically 
using saliva or blood samples. We excluded participants with an 
acute physical or mental health condition, although when such 
participants recovered they were eligible for the study.
Ethical approval and consent. Ethical approval was obtained for 
the LonDownS study from the North West Wales Research Eth-
ics Committee (13/WA/0194). Participants with and without the 
capacity to consent were able to participate. Where individuals 
had capacity to consent we obtained written informed consent. 
Where individuals did not have capacity to consent a consultee 
was appointed and asked to sign a form to indicate their decision 
regarding the individual’s inclusion based on their knowledge of 
the individual and his/her wishes, in accordance with the UK 
Mental Capacity Act 2005.
Assessment battery
Our battery was based on several established and novel assess-
ments relevant to the cognitive profile and development of demen-
tia in DS, including the Arizona Cognitive Test Battery (ACTB) 
(Edgin et al., 2010) which includes several computer tasks from the 
Cambridge Neuropsychological Test Automated Battery (CANTAB) 
(CANTAB®, 2016). The ACTB was developed to assess a range 
of skills relevant to those brain areas most affected in DS, to have 
variable scores with low floor effects that are suitable for a range 
of ages and contexts, to be suitable for a non-verbal population, 
and to show good test-retest reliability. This battery was validated 
using individuals with DS aged 7–38. However, our previous pilot 
work showed some components of the ACTB had significant floor 
effects in older adults aged 45+ with DS, and some tests form-
ing part of the battery were not able to distinguish between those 
with and without dementia (Sinai et al., 2016).
We therefore made several modifications to the ACTB. We excluded 
some tests for older adults (Cohort 1) based on our pilot results, 
specifically the virtual generated arena, cats and frogs, and finger 
sequencing. We added comparable table-top tests as our previous 
studies have supported their use in people with DS and found lower 
floor effects compared to computer tasks (Sinai et al., 2016). We 
also added informant-rated tools to cover similar cognitive domains 
as the neuropsychological test battery, allowing us to collect data on 
those unable to engage in cognitive testing.
A summary table of assessments can be found in the 
Supplementary material S1.
Test administration. To avoid excessive burden to participants 
who were unable to engage in formal assessment and follow 
simple instructions (e.g. those with more severe dementia) the 
battery was only administered to those who were able to under-
stand, meet thresholds for, and respond to the Kay vision test 
(Kay, 1983), the Whisper hearing test (Prescott et al., 1999) and the 
first question of the KBIT-2 (Kaufman & Kaufman, 2004). Adults 
who did not meet these thresholds did not complete any further 
tests in the battery, though their carers completed all informant 
questionnaires. In addition, we used the motor screening task 
(MOT) from the CANTAB (CANTAB®, 2016) to familiarise 
participants with using the touchscreen. For this participants were 
required to press a cross on the screen at different locations for 
10 trials.
Task order was counter-balanced across participants (see 
Supplementary material S2). We used a fixed order, but took a 
pragmatic approach that allowed flexibility where necessary. The 
assessment was completed in one session where possible, approxi-
mately 3 hours in duration, with a 10 minute break in the middle 
and additional breaks as necessary. Assessments took place where 
convenient for participants, usually in their homes, and occa-
sionally using our testing rooms. Notes about the participant’s 
attention, co-operation, affect, and anxiety were made where 
appropriate throughout the assessment, including reasons for non-
completion of tasks.
Vision and hearing assessment
Kay vision test. Participants’ visual acuity, wearing correction if 
appropriate, was tested using the Kay vision test (Kay, 1983). Par-
ticipants were asked to identify increasingly small pictures from 
3m away, verbally or by pointing to the screening card, and the 
smallest size the participant could see was recorded. A threshold of 
3/19 was used to identify those with significant vision problems that 
would invalidate cognitive test results. Only participants who met 
this threshold were administered further cognitive tasks.
Whisper hearing test. Participants’ hearing abilities, using cor-
rection if appropriate, were tested using the Whisper test (Prescott 
et al., 1999), adapted for individuals with ID. The researcher 
stood behind the participant, 50cm from the midpoint between 
the ears on the top of the head, and whispered the name of one of 
eight objects (toothbrush, popcorn, ice cream, snowman, reindeer, 
hotdog, football, seesaw) displayed on the participant’s test card. 
Words were simple spondee words, i.e. contained two syllables 
with equal stress on each. The participant was asked to repeat the 
word or point to the correct picture. If the participant was unable 
to hear a whispered word a conversational, then loud voice, was 
used. The quietest level heard was recorded. Only participants who 
were able to hear and respond correctly to at least a loud voice 
were administered further cognitive tasks.
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Test of general abilities
KBIT-2. We assessed general cognitive abilities using the Kaufman 
Brief Intelligence Test 2 (KBIT-2) (Kaufman & Kaufman, 2004). 
The KBIT-2 consists of three subtests, two of which assess verbal 
IQ (verbal knowledge and riddles) and one assessing non-verbal 
IQ (matrices). Each subtest was started at item 1, and stopped after 
4 consecutive incorrect answers. The KBIT-2 provides raw scores 
or age-dependent IQ scores. As we expected significant floor 
effects for IQ scores (i.e. an IQ of 40), we used raw scores as the 
main measure of general ability.
Tests of memory
CANTAB – PAL. The paired associates learning (PAL) task is a 
measure of visuospatial short-term memory from the CANTAB 
(CANTAB®, 2016). Participants were required to remember loca-
tions of an increasing number of patterns in progressive stages, 
hidden behind boxes on the screen. If a particular stage was not 
completed in a maximum of 10 attempts the test terminated. The 
main outcome from this test was the first trial memory score: the 
number of pattern locations correctly remembered on the first trial 
for each stage attempted. The secondary outcome was the number 
of stages completed.
CAMCOG – delayed incidental memory, verbal fluency and ori-
entation. The Cambridge Cognitive Examination (CAMCOG) is 
a series of neuropsychological tests from the Cambridge Mental 
Disorders of the Elderly Examination (CAMDEX), used to assess 
cognitive impairments associated with dementia (Roth et al., 1986), 
and adapted to assess cognitive abilities in people with DS (Hon 
et al., 1999). The three tests used in our battery assess short-term 
memory (delayed incidental memory), frontal function (semantic 
verbal fluency) and participants’ knowledge of when it is (i.e. the 
day, month and year) and where they are (orientation).
Firstly, participants were administered the picture naming task, in 
which they were shown 6 pictures of objects and asked to name 
them. There were then two distractor tasks before incidental 
memory was tested: the verbal fluency task (see under tests of 
executive function) and the orientation task, in which participants 
were asked their full name, the day of the week, the month, the 
year, where they are, and the nearest city/town. For the orienta-
tion task the outcome is calculated from the number of questions 
answered correctly, with fewer points given if a clue was required. 
Finally, the delayed incidental memory task required participants to 
freely recall the pictures they saw earlier, then recognise them from 
3 options. The outcomes for the incidental memory task were the 
number of objects correctly recalled and recognised.
Delayed object memory. This test is a measure of short-term 
memory, based on the Fuld object memory test (Fuld, 1980). 
We adapted this task to use 7 objects (toothbrush, comb, spoon, 
pencil, watch, coin and key) rather than 10 to reduce the mem-
ory load for participants. We also added a delayed memory trial 
(5 minute delay) in addition to two immediate memory trials to 
assess delayed as well as immediate memory. At the start of each 
trial participants named all seven objects and were instructed to 
remember them; any objects not correctly identified were named by 
the examiner. Participants’ memory was tested during two imme-
diate recall trials followed by one 5-minute delayed recall trial. 
Immediately following each recall trial any objects not remembered 
were shown to the participant. During the delay wherever possible 
we collected physical measurements (height, weight, abdominal/
head/neck circumference, gait, blood pressure, and pulse) from the 
participant. The outcome measures were the total number of objects 
correctly remembered in the two immediate memory trials com-
bined and in the delayed memory trial.
NAID – memory for sentences. This test of verbal memory is taken 
from the Neuropsychological Assessment of Dementia in Adults 
with Intellectual Disabilities (NAID) (Oliver et al., 1998). At 
baseline this test was administered to Cohort 2 only. Participants 
were asked to repeat 6 sentences after the researcher. The outcome 
measure was the number of words correctly remembered.
ACTB – virtual generated arena. The virtual generated arena is 
a measure of visuospatial short-term memory, taken from the 
ACTB (Edgin et al., 2010). This task was adapted from the C–G 
arena (Thomas et al., 2001) and is based on the Morris water maze 
from the animal literature (Morris, 1984). The arena task was only 
administered to Cohort 2. This task required participants to learn 
and remember where a hidden carpet was in a virtual room, using 
visual cues around the room. The main outcome was the percentage 
of time searching in the correct quadrant in the final test trial when 
no carpet is present.
Tests of executive function
CANTAB – IED. The intra/extra dimensional set shift (IED) task 
is a measure of rule learning and set shifting from the CANTAB 
(CANTAB®, 2016). Participants were required to learn rules about 
which was the ‘correct’ of two presented patterns. When a rule was 
established (6 consecutive correct answers) there was a rule change 
and participants were required to learn a new rule in the next stage. 
If a particular stage was not complete (i.e. that rule was not ‘learnt’) 
in a maximum of 50 trials the task terminated. The two main 
outcome measures were the number of stages completed (measure 
of set shifting) and the number of stage 1 errors (measure of rule 
learning). Completing stages 2–7 required an intra-dimensional 
shift, completing stages 8–9 required an extra-dimensional shift 
(stage 1 required rule learning only with no shift).
CANTAB – SRT. The simple reaction time (SRT) task from the 
CANTAB was originally proposed as a measure of attention 
(CANTAB®, 2016), and was included in the ACTB as a measure 
of motor abilities (Edgin et al., 2010). Participants were required 
to press a button as soon as a white square appeared on the 
computer screen. There was an initial practice block of 24 trials, 
followed by two test blocks of 50 trials each. Outcome meas-
ures of interest were the standard deviation of the response time, 
which allows an estimate of consistency in response time and 
thus reflects attention levels during the task, the total number of 
correct responses, and mean response time.
Semantic verbal fluency. Verbal fluency is a measure of frontal 
function (Elfgren & Risberg, 1998). Participants were asked to 
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name as many animals as they could in 1 minute. The main outcome 
was the number of unique animals named (including age and sex 
variations). The number of animals repeated and the total number 
of repetitions are outcomes of future interest.
Tower of London. The Tower of London is intended to assess 
working memory and planning (Shallice, 1982). Participants were 
required to move beads on a board to match presented configu-
rations. We used a modified version of this task (Strydom et al., 
2007), consisting of problems 1 to 5 from Krikorian et al. (1994) 
which can be completed in a minimum of 2–4 moves. Before 
commencing, the participant’s ability to name the colour of each 
bead was tested to ensure they could distinguish between them 
(e.g. they were not red-green colour blind). The outcome measure 
was calculated from the number of trials completed, with 2 points 
for trials completed in the minimum number of moves and 1 point 
for trials completed with more moves.
ACTB – cats and frogs. The cats and frogs test measures rule 
learning and switching, inhibitory control, and working memory 
(Edgin et al., 2010) and is based on the Dots test (Davidson et al., 
2006). We only administered this test to Cohort 2. Participants were 
required to learn two different rules in Stages 1 and 2 (the ‘cat’ and 
‘frog’ rules respectively), and then combine them in Stage 3. For 
the ‘cat’ rule participants were required to press a button on the 
same side of the screen as the cat, for the ‘frog’ rule participants 
were required to press a button on the opposite side of the screen 
as the frog. Stage 1 contained 6 practice and 12 test trials, Stage 2 
contained 4 practice and 12 test trials, and Stage 3 contained 33 
test trials. We used the percentage of trials correctly completed for 
each stage as the outcome; Stages 1 and 2 rely on rule learning 
while Stage 3 relies on rule switching and inhibitory control. As 
piloting revealed some individuals showed response times that 
were too slow for the original version we amended the task to 
allow unlimited response times (Startin et al., unpublished obser-
vations). We also changed the cat colour to orange from white to 
contrast the green frog.
Tests of motor coordination
Finger-nose pointing. The finger-nose pointing test is a clinical 
measure of motor coordination (Desrosiers et al., 1995). Using 
the index finger on their dominant hand, participants alternatively 
pointed to the tip of their nose and a red circle with a 2cm diameter, 
45cm away, as quickly as possible for 20 seconds. The outcome 
measure was the total number of times the participant pointed to 
the red circle.
NEPSY-II – visuomotor precision. This task measures hand-eye 
coordination, and is taken from the Developmental NEuroPSY-
chological Assessment-II (NEPSY-II) (Korkman et al., 2007). 
Participants were timed as they traced train, car, and motorbike 
tracks (divided into squares), with a time limit of 180s for each 
track. The number of errors was calculated for each track (defined 
as those squares where the line went outside the track, there was a 
broken line due to a pen lift, or squares not completed in the time 
limit). Error scores and times were used to determine an overall 
score firstly for the train and car tracks combined and secondly the 
car and motorbike tracks combined using provided tables.
ACTB – finger sequencing. The finger sequencing task is a 
measure of motor coordination. This task was adapted for the 
ACTB (Edgin et al., 2010) and administered to Cohort 2 only. 
Participants were required to tap a button as fast as possible 
using a variety of specified sequences, with a 10 second practice 
and 30 second test trial for each sequence. The total number of 
sequences completed was the main outcome used.
Informant questionnaires
Informants completed a series of questionnaires about the partici-
pant while the participant was administered the cognitive battery. 
Informants were usually relatives or paid carers. Missing items from 
the DLD, OMQ and BRIEF-A were imputed for up to 15% of items 
within each domain by checking and imputing the nearest integer 
to the mean value of completed scores within that domain by hand. 
All reported measures for these questionnaires use the total scores 
including imputed values where relevant.
Short ABS. The Short Adaptive Behavior Scale (short ABS) 
(Hatton et al., 2001), adapted from the Adaptive Behavior Scale – 
Residential and Community (Part I) (Nihira et al., 1993), recorded 
participants’ everyday adaptive abilities.
DLD. The Dementia for Learning Disabilities (DLD) questionnaire 
is a measure of behaviours associated with cognitive decline in 
people with ID over the last two months (Evenhuis, 1996).
OMQ. The Observer Memory Questionnaire (OMQ) is an inform-
ant reported questionnaire relating to individuals’ memory abilities 
over the last two months (O’Shea, 1996).
BRIEF-A. The Behavior Rating Inventory of Executive Function 
– Adult version (BRIEF-A) (Roth et al., 2005) provides scores for 
informant reported problems with behaviours relating to executive 
functioning over the last month.
Statistical analysis
The results presented here are limited to cross-sectional analyses 
of cognitive task data and related informant questionnaires. All 
statistical analyses were performed using SPSS version 22. We 
determined the number of individuals who completed each task, 
and for each outcome measure of interest calculated the mean, 
standard deviation and range of scores. As many variables devi-
ated from normality as assessed using the Shapiro-Wilk test, with 
alpha set to p<0.01 to account for multiple comparisons, we also 
calculated medians and interquartile ranges. We determined the 
percentage of individuals at floor and ceiling level for each outcome 
of those who were able to complete the task (i.e. the number of indi-
viduals scoring the lowest and highest possible scores respectively). 
We compared responses between males and females in Cohort 2 
using Student’s t-tests or Mann-Whitney U tests as appropriate. 
Correlation analyses were performed for Cohort 2 using Pearson’s 
correlation or Spearman’s rho as appropriate to assess concurrent 
validity and to determine the relationships between selected test 
scores; for these alpha was set to p<0.01 due to multiple compari-
sons. Absolute values of correlation coefficients of 0.70 and above 
were considered strong, between 0.50 and 0.69 were considered 
moderate, and between 0.30 and 0.49 were considered weak.
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Results
Task completion and score distributions
Raw scores for KBIT-2 and total scores for informant 
questionnaires 
 
4 Data files
http://dx.doi.org/10.6084/m9.figshare.4206429.v1
Cohort 1: adults aged 36 years and over without dementia. Demo-
graphic information of 130 adults aged 36+ years without a clinical 
diagnosis of dementia is shown in Table 1. Nine (6.9%) participants 
were unable to undertake any tasks (one of whom did not under-
stand English) and a further 12 (9.2%) participants did not pass the 
vision and hearing tests. All data relating to cognitive task comple-
tion and performance for this group are presented for 109 adults 
in Table 2, and data from informant questionnaires are shown in 
Table 3.
Completion rates for each cognitive task in our battery were accept-
able, approximately 90% for all non-computer tasks and 80% for 
computer tests. For those who completed the tasks many outcomes 
showed fewer than 10% of participants at floor and fewer than 20% 
of participants at ceiling. As anticipated, when converting KBIT-2 
raw scores to IQ we found a high number of adults at floor, with 70 
(66.7%) adults at floor for verbal IQ and 41 (39.4%) adults at floor 
for non-verbal IQ. The majority of outcomes from the informant 
questionnaires showed low floor and ceiling effects.
Cohort 1: adults aged 36 years and over with dementia. Infor-
mation about the demographics of 51 individuals with clinically 
diagnosed dementia is shown in Table 1. Of these, 22 had a diag-
nosis of AD, 1 a diagnosis of vascular dementia, 1 a diagnosis of 
dementia with Lewy bodies, and 27 had dementia of unspecified 
type. The mean age of dementia diagnosis was 51.70 years (SD 
6.80, range 35–65 years), with a mean time since diagnosis of 2.46 
years (SD 2.42, range 0–11 years). Of the adults in this group, 15 
(29.4%) were unable to undertake any cognitive task with a further 
9 (17.6%) failing the vision or hearing task. All data relating to 
cognitive task completion and performance for this group are 
presented for 27 individuals in Table 4, with data from informant 
questionnaires in Table 5.
Completion rates for adults with dementia were lower than for those 
without dementia. Almost all tasks showed completion rates above 
65%. For those able to complete the task the majority of outcomes 
showed fewer than 25% of individuals at floor and fewer than 15% 
of participants at ceiling. Again, we found high floor effects when 
converting KBIT-2 raw scores to IQ, with 21 (84.0%) adults at floor 
for verbal IQ and 15 (62.5%) adults at floor for non-verbal IQ. From 
the informant questionnaires, domains showed minimal floor and 
ceiling effects.
Cohort 2: adults aged 16–35 years. Analyses were conducted for 
124 adults aged 16–35 years. Demographic information is shown 
in Table 1. Of these, three (2.4%) did not pass the vision test, and 
so results relating to cognitive task performance for this group are 
presented for 121 individuals in Table 6 with data from informant 
questionnaires in Table 7.
We found high completion rates across the tasks in the battery, with 
the majority above 85% and many of the lower completion rates for 
some of the computer tasks being due to technical problems. For 
those who completed the tasks there were low floor effects, with 
many outcomes having fewer than 5% of participants at floor. Some 
outcomes however showed relatively high ceiling effects, though 
many were below 35%. When converting raw KBIT-2 scores to IQ 
we again found high floor effects, with 61 (50.8%) adults at floor 
for verbal IQ and 41 (33.9%) adults at floor for non-verbal IQ. The 
majority of domains from the informant questionnaires showed low 
floor and ceiling effects, although ceiling effects were found in over 
20% of individuals for domains in the short ABS and DLD.
Comparing scores for males and females in Cohort 2
There was no significant difference in age between males and 
females (t(122)=-0.854, p=0.395, males M 24.80 SD 5.79, females 
M 25.65 SD 5.29, 95% CI (-2.82, 1.12)). Females showed sig-
nificantly better performance on the verbal subtests of the KBIT-2 
(t(109.5)=-2.15, p=0.034, 95% CI (-12.40, -0.50)). For the inform-
ant questionnaires females showed better cognitive abilities as 
assessed by the DLD cognitive domain (p=0.041). There were no 
other significant differences in performance between males and 
females (all p>0.05; see Table 8 and Table 9). Within Cohort 2 
there were no significant correlations with age for any cognitive 
test outcomes or informant questionnaire scores (all p>0.05; see 
Table 10 and Table 11).
Table 1. Participant demographics across the groups.
Adults aged 36+ without 
dementia
Adults aged 36+ with dementia Adults aged 16–35
Number 130 51 124
Age (mean±SD 
(range))
47.77±7.01 (36–71) 54.20±6.95 (38–67) 25.24±5.53 (16–35)
Sex 74 males, 56 females 22 males, 29 females 59 males, 65 females
ID severity 
(carer report)
55 mild, 53 moderate, 
22 severe
16 mild, 22 moderate, 8 severe, 
5 unknown (NB pre-dementia)
48 mild, 63 moderate, 13 
severe
Ethnicity 112 white, 4 Asian, 
10 African, 3 mixed, 1 other
48 white, 2 Asian, 1 African 101 white, 6 Asian,  
7 African, 7 mixed, 3 other
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Table 2. Task completion rates and summary of results for main outcome measures for adults aged 36+ without dementia. 
a Significantly deviated from normality using Shapiro-Wilk test (P<0.010), b lower values indicate better performance, c 0 errors is at ceiling.
Test Number 
completed
Reasons 
for non-
completion
Outcome 
measure
Mean ± 
SD
Median 
(IQR)
Range Number 
at floor
Number at 
ceiling
KBIT-2 105 (96.3%) 
verbal, 104 
(95.4%) non-
verbal
5 unable to 
complete
Verbal raw score 30.55 ± 
17.47
28.00 
(24.00)
2 – 80 0 (0.0%) 0 (0.0%)
Performance raw 
scorea
12.55 ± 
6.57
14.00 
(7.00)
0 – 32 7 (6.7%) 0 (0.0%)
CANTAB – PAL 91 (83.5%) 10 refused
8 unable to 
complete
First trial memory 
scorea
7.00 ± 
5.86
6.00 
(11.00)
0 – 21 15 
(16.5%)
0 (0.0%)
Levels completeda 4.98 ± 
2.65
5.00 
(6.00)
0 – 8 5 (5.5%) 23 (25.3%)
CAMCOG – delayed 
incidental memory
100 (91.7%) 7 refused
2 unable to 
complete
Object naminga 5.65 ± 
0.70
6.00 
(1.00)
3 – 6 0 (0.0%) 75 (75.0%)
Object recalla 0.52 ± 
1.05
0.00 
(1.00)
0 – 6 72 
(72.0%)
1 (1.0%)
Object 
recognitiona
3.47 ± 
1.85
4.00 
(3.00)
0 – 6 6 (6.0%) 18 (18.0%)
CAMCOG –
orientation
100 (91.7%) 6 refused
3 unable to 
complete
Total scorea 8.87 ± 
3.56
10.50 
(6.00)
0 – 12 1 (1.0%) 40 (40.0%)
Delayed object 
memory
97 (89.0%) 6 refused 
4 unable to 
complete 
2 technical 
problems
Immediate 
memorya
9.09 ± 
3.17
10.00 
(5.00)
0 – 14 2 (2.1%) 4 (4.1%)
Delayed memorya 5.07 ± 
1.80
5.00 
(2.00)
0 – 7 3 (3.1%) 22 (22.7%)
CANTAB – IED 89 (81.7%) 14 refused 
5 unable to 
complete 
1 technical 
problems
Errors in stage 1a b 6.29 ± 
9.17
2.00 
(5.50)
0 – 33 0 (0.0%) 11 (12.4%)c
Levels completeda 5.83 ± 
3.07
7.00 
(3.00)
0 – 9 13 
(14.6%)
17 (19.1%)
CANTAB – SRT 84 (77.1%) 13 refused 
7 unable to 
complete 
5 technical 
problems
Total correcta 87.07 ± 
17.29
94.00 
(17.25)
25 – 100 0 (0.0%) 13 (15.5%)
Mean latency 
(ms)a b
950.37 
± 
480.55
853.78 
(631.36)
311.33 
– 2241.61
N/A N/A
Latency standard 
deviation (ms)b
445.17 
± 
216.29
426.63 
(349.09)
45.32 
– 980.98
N/A N/A
CAMCOG – verbal 
fluency
101 (92.7%) 6 refused 
2 unable to 
complete
Total animals 
nameda
8.40 ± 
5.86
8.00 
(8.00)
0 – 27 6 (5.9%) N/A
Tower of London 97 (89.0%) 5 refused 
6 unable to 
complete 
1 technical 
problems
Total scorea 6.37 ± 
3.23
8.00 
(5.00)
0 – 10 8 (8.2%) 17 (17.5%)
Finger-nose pointing 98 (89.9%) 9 refused 
2 unable to 
complete
Total completeda 8.49 ± 
4.83
8.00 
(6.00)
0 – 23 2 (2.0%) N/A
NEPSY-II – 
visuomotor precision
97 (89.0%) 
train and car, 
96 (88.1%) 
car and 
motorbike
10 refused 
2 unable to 
complete 
1 technical 
problems
Train and cara 13.52 ± 
5.88
15.00 
(8.00)
1 – 23 0 (0.0%) 0 (0.0%)
Car and 
motorbikea
11.45 ± 
8.72
9.00 
(15.00)
0 – 32 3 (3.1%) 0 (0.0%)
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Table 3. Summary of results from informant questionnaires for adults aged 36+ without dementia. a Significantly 
deviated from normality using Shapiro-Wilk test (P<0.010), b higher scores indicate poorer abilities.
Questionnaire Outcome measure Number 
completed
Mean ± SD Median 
(IQR)
Range Number at 
floor
Number at 
ceiling
Short ABS Total score 112 (86.2%) 71.89 ± 23.39 75.00 
(38.50)
14 – 111 0 (0.0%) 0 (0.0%)
Personal self-
sufficiencya
117 (90.0%) 26.74 ± 6.07 29.00 
(6.00)
0 – 33 1 (0.9%) 14 (12.0%)
Community self-
sufficiency
115 (88.5%) 24.57 ± 12.06 24.00 
(17.00)
0 – 47 1 (0.9%) 0 (0.0%)
Personal-social 
responsibilitya
116 (89.2%) 20.78 ± 6.97 21.00 
(10.75)
3 – 32 0 (0.0%) 1 (0.9%)
DLDb Sum of cognitive 
scorea
110 (84.6%) 12.23 ± 10.74 9.00 
(16.50)
0 – 38 0 (0.0%) 12 (10.9%)
Sum of social scoresa 113 (86.9%) 11.58 ± 7.75 11.00 
(10.00)
0 – 36 0 (0.0%) 6 (5.3%)
OMQb Total score 111 (85.4%) 82.50 ± 18.85 83.00 
(26.00)
35 – 125 0 (0.0%) 0 (0.0%)
BRIEF-Ab Total score 100 (76.9%) 122.11 ± 24.11 122.00 
(37.50)
74 – 175 0 (0.0%) 0 (0.0%)
Behavioural regulation 
index
117 (90.0%) 52.02 ± 11.21 51.00 
(16.00)
30 – 80 0 (0.0%) 2 (1.7%)
Metacognition index 101 (77.7%) 70.91 ± 14.71 72.00 
(22.50)
43 – 100 0 (0.0%) 0 (0.0%)
Correlations between outcome scores for Cohort 2
The majority of cognitive test outcomes showed significant 
correlations with all other outcomes in the battery (p<0.01), with 
the exception of the computer generated arena which showed no 
significant correlations at the p<0.01 level (Table 10). All out-
comes from the informant questionnaires showed significant cor-
relations with each other (see Table 11). Due to a high number of 
adults aged 16–35 scoring at or close to ceiling in the DLD domains 
these scores were not included in correlational analyses. To better 
investigate the relationships between test outcomes we considered 
the absolute values of correlation coefficients.
Moderate and strong correlations revealed four clusters of test 
outcomes within our cognitive data. One cluster contained PAL 
first trial memory score and object memory immediate score 
(r=0.522), suggesting this is a visuospatial memory cluster. Another 
contained SRT mean latency and latency standard deviation, 
finger-nose pointing and finger sequencing (0.539<r<0.628), sug-
gesting this is a motor coordination cluster. The next contained 
memory for sentences and verbal fluency (r=0.593). These two 
tasks also correlated highly with KBIT-2 verbal and non-verbal 
scores (0.503<r<0.827), in particular the former, suggesting this 
represents a language cluster. The final cluster contained outcomes 
that were not all necessarily related to each other but were related 
to at least two other outcomes in the cluster; this consisted of PAL 
first trial memory score, SRT mean latency and latency standard 
deviation, Tower of London, finger-nose pointing and NEPSY-II 
visuomotor precision car and motorbike (0.271<r<0.614). Again, 
most of this cluster correlated with KBIT-2 verbal and non-verbal 
scores (0.380<r<0.636). This cluster may be related to processing 
speed and sustained attention. Finally, the cats and frogs Stage 3 
score also correlated highly with KBIT-2 verbal and non-verbal 
scores (r=0.568 and r=0.541 respectively), suggesting performance 
on this task is highly related to general abilities.
Within the informant questionnaire outcomes the best correlations 
were between subscales related to complex adaptive functioning 
such as personal-social responsibility and higher cognitive func-
tions (Short ABS Personal-social responsibility and OMQ r=-0.631, 
Short ABS Personal-social responsibility and BRIEF-A Metacogni-
tion index r=-0.731).
Discussion
Here we describe a cognitive test battery to provide detailed assess-
ment of cognitive abilities in individuals with DS, along with data 
for test completion and outcomes. We deliberately assessed indi-
viduals with a wide range of ages and ID severities and those with 
and without a clinical diagnosis of dementia, in order to provide 
cognitive test data that is representative of the adult population 
with DS. Results from individuals without dementia suggest high 
completion rates across the tasks. Computer-based tasks had lower 
completion rates, in some cases (up to 27.3%) due to technical 
issues. Completion rates for those with dementia were lower, with 
approximately half of individuals unable to undertake any task. Our 
outcome measures for each task and informant measure showed a 
range of scores, with many showing low floor and ceiling effects. 
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Table 4. Task completion rates and summary of results for main outcome measures for adults aged 36+ with dementia. 
a
 
Significantly deviated from normality using Shapiro-Wilk test (P<0.010), b lower values indicate better performance, c 0 errors is at ceiling.
Test Number 
completed
Reasons 
for non-
completion
Outcome 
measure
Mean ± SD Median 
(IQR)
Range Number 
at floor
Number 
at ceiling
KBIT-2 25 (92.6%) 
verbal, 24 
(88.9%) non-
verbal
3 unable to 
complete
Verbal raw score 18.68 ± 
13.77
17.00 
(24.00)
1 – 51 0 (0.0%) 0 (0.0%)
Performance raw 
score
8.29 ± 6.45 8.00 (12.00) 0 – 19 4 (16.7%) 0 (0.0%)
CANTAB – PAL 20 (74.1%) 2 refused 
5 unable to 
complete
First trial memory 
scorea
1.70 ± 2.58 0.50 (2.75) 0 – 9 10 
(50.0%)
0 (0.0%)
Levels completed 2.40 ± 2.09 2.00 (4.50) 0 – 6 5 (25.0%) 0 (0.0%)
CAMCOG 
– delayed 
incidental 
memory
25 (92.6%) 2 unable to 
complete
Object naminga 5.40 ± 0.87 6.00 (2.00) 4 – 6 0 (0.0%) 16 (64.0%)
Object recalla 0.16 ± 0.47 0.00 (0.00) 0 – 2 22 
(88.0%)
0 (0.0%)
Object recognition 2.84 ± 1.70 2.00 (2.00) 0 – 6 1 (4.0%) 3 (12.0%)
CAMCOG 
– orientation
23 (85.2%) 3 unable to 
complete 
1 technical 
problems
Total score 5.65 ± 3.92 5.00 (7.00) 0 – 12 2 (8.7%) 2 (8.7%)
Delayed object 
memory
21 (77.8%) 3 unable to 
complete 
3 technical 
problems
Immediate 
memorya
4.62 ± 4.12 3.00 (8.00) 0 – 11 5 (23.8%) 0 (0.0%)
Delayed memory 2.67 ± 2.22 2.00 (5.00) 0 – 7 5 (23.8%) 1 (4.8%)
CANTAB – IED 20 (74.1%) 1 refused 
6 unable to 
complete
Errors in stage 1a b 13.70 ± 
12.91
7.00 (23.75) 0 – 39 0 (0.0%) 3 (15.0%)c
Levels completeda 3.30 ± 3.39 1.50 (7.00) 0 – 8 8 (40.0%) 0 (0.0%)
CANTAB – SRT 17 (63.0%) 3 refused 
7 unable to 
complete
Total correct 73.88 ± 
18.83
72.00 
(36.00)
41 – 99 0 (0.0%) 0 (0.0%)
Mean latency 
(ms)b
1293.65 ± 
488.29
1160.93 
(893.95)
588.00 
– 
2153.17
N/A N/A
Latency standard 
deviation (ms)b
574.87 ± 
166.43
609.07 
(252.62)
219.57 
– 
815.67
N/A N/A
CAMCOG 
– verbal fluency
25 (92.6%) 2 unable to 
complete
Total animals 
nameda
5.00 ± 4.51 5.00 (7.00) 0 – 19 4 (16.0%) N/A
Tower of 
London
16 (59.3%) 11 unable to 
complete
Total score 4.88 ± 3.79 5.50 (8.00) 0 – 10 3 (18.8%) 3 (18.8%)
Finger-nose 
pointing
23 (85.2%) 2 refused 
2 unable to 
complete
Total completeda 5.61 ± 5.09 3.00 (9.00) 0 – 15 2 (8.7%) N/A
NEPSY-II 
– visuomotor 
precision
19 (70.4%) 
train and car, 
18 (66.7%) 
car and 
motorbike
1 refused 
8 unable to 
complete
Train and car 11.00 ± 7.57 11.00 
(15.00)
0 – 21 1 (5.3%) 0 (0.0%)
Car and motorbike 7.67 ± 7.90 5.00 (13.00) 0 – 24 4 (22.2%) 0 (0.0%)
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Table 5. Summary of results from informant questionnaires for adults aged 36+ with dementia. 
a Significantly deviated from normality using Shapiro-Wilk test (P<0.010), b higher scores indicate poorer 
abilities.
Questionnaire Outcome 
measure
Number 
completed
Mean ± 
SD
Median 
(IQR)
Range Number 
at floor
Number 
at ceiling
Short ABS Total score 43 (84.3%) 42.23 ± 
24.51
38.00 
(42.00)
3 – 92 0 (0.0%) 0 (0.0%)
Personal self-
sufficiency
43 (84.3%) 17.02 ± 
9.70
17.00 
(18.00)
0 – 33 1 (2.3%) 1 (2.3%)
Community self-
sufficiencya
43 (84.3%) 11.98 ± 
9.11
10.00 
(15.00)
0 – 31 1 (2.3%) 0 (0.0%)
Personal-social 
responsibility
43 (84.3%) 13.23 ± 
7.32
13.00 
(11.00)
1 – 28 0 (0.0%) 0 (0.0%)
DLDb Sum of cognitive 
score
42 (82.4%) 27.69 ± 
10.53
29.00 
(13.25)
3 – 44 1 (2.4%) 0 (0.0%)
Sum of social 
scores
42 (82.4%) 23.93 ± 
12.01
25.00 
(22.00)
1 – 50 0 (0.0%) 0 (0.0%)
OMQb Total score 37 (72.5%) 117.16 ± 
13.82
119.00 
(13.50)
78 – 142 0 (0.0%) 0 (0.0%)
BRIEF-Ab Total score 33 (64.7%) 145.36 ± 
31.54
149.00 
(40.50)
77 – 199 0 (0.0%) 0 (0.0%)
Behavioural 
regulation index
37 (72.5%) 57.22 ± 
14.71
54.00 
(21.00)
32 – 84 0 (0.0%) 0 (0.0%)
Metacognition 
index
33 (64.7%) 88.24 ± 
19.53
94.00 
(30.00)
43 – 118 0 (0.0%) 0 (0.0%)
Table 6. Task completion rates and summary of results for main outcome measures for adults aged 16–35. a Significantly deviated 
from normality using Shapiro-Wilk test (P<0.010), b lower values indicate better performance, c 0 errors is at ceiling.
Test Number 
completed
Reasons 
for non-
completion
Outcome 
measure
Mean ± 
SD
Median 
(IQR)
Range Number 
at floor
Number at 
ceiling
KBIT-2 120 (99.2%) 
verbal, 121 
(100.0%) non-
verbal
1 unable to 
complete
Verbal raw score 35.03 ± 
16.77
35.00 (23.00) 2 – 82 0 (0.0%) 0 (0.0%)
Performance raw 
scorea 
14.98 ± 
6.90
16.00 (7.00) 0 – 32 5 (4.1%) 0 (0.0%)
CANTAB – PAL 108 (89.3%) 5 refused 
7 unable to 
complete 
1 technical 
problems
First trial memory 
scorea 
10.22 ± 
5.66
11.00 (7.75) 0 – 20 10 (9.3%) 0 (0.0%)
Levels 
completeda 
6.29 ± 
2.50
8.00 (2.00) 0 – 8 4 (3.7%) 56 (51.9%)
CAMCOG 
– delayed 
incidental 
memory 
117 (96.7%) 1 refused 
2 unable to 
complete 
1 technical 
problems
Object naminga 5.74 ± 
0.68
6.00 (0.00) 2 – 6 0 (0.0%) 98 (83.8%)
Object recalla 1.19 ± 
1.42
1.00 (2.00) 0 – 6 53 (45.3%) 1 (0.9%)
Object 
recognitiona 
4.30 ± 
1.59
5.00 (3.00) 0 – 6 2 (1.7%) 34 (29.1%)
CAMCOG 
– orientation 
113 (93.4%) 1 refused 
4 unable to 
complete 
3 technical 
problems
Total scorea 9.65 ± 
3.45
12.00 (4.00) 1 – 12 0 (0.0%) 65 (57.5%)
Delayed object 
memory 
109 (90.1%) 2 refused 
3 unable to 
complete 
7 technical 
problems
Immediate 
memorya 
10.35 ± 
2.83
11.00 (3.00) 0 – 14 2 (1.8%) 3 (2.8%)
Delayed 
memorya 
5.84 ± 
1.42
6.00 (2.00) 0 – 7 1 (0.9%) 43 (39.4%)
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Test Number 
completed
Reasons 
for non-
completion
Outcome 
measure
Mean ± 
SD
Median 
(IQR)
Range Number 
at floor
Number at 
ceiling
Memory for 
sentences 
106 (87.6%) 2 refused 
10 unable to 
complete 
3 technical 
problems
Total words 
remembereda 
30.53 ± 
13.68
33.50 (23.00) 3 – 49 0 (0.0%) 3 (2.8%)
ACTB – virtual 
generated arena 
73 (60.3%) 4 refused 
11 unable to 
complete 
33 technical 
problems
Percentage of 
time spent in 
correct quadranta 
26.52 ± 
19.88
22.36 (21.04) 0.00 
– 86.79
8 (11.0%) 0 (0.0%)
CANTAB – IED 109 (90.1%) 2 refused 
6 unable to 
complete 
4 technical 
problems
Errors in stage 
1a b 
4.19 ± 
7.16
2.00 (3.00) 0 – 33 0 (0.0%) 19 
(17.4%)c 
Levels 
completeda 
6.57 ± 
2.54
7.00 (1.00) 0 – 9 9 (8.3%) 22 (20.2%)
CANTAB – SRT 105 (86.8%) 3 refused 
6 unable to 
complete 
7 technical 
problems
Total correcta 92.82 ± 
13.30
98.00 (8.00) 13 – 100 0 (0.0%) 35 (33.3%)
Mean latency 
(ms)a b 
692.48 
± 
442.59
553.77 
(462.81)
273.37 
– 2500.61
N/A N/A
Latency standard 
deviation (ms)a b 
315.93 
± 
208.43
274.23 
(295.32)
32.94 
– 950.49
N/A N/A
CAMCOG 
– verbal fluency 
114 (94.2%) 1 refused 
5 unable to 
complete 
1 technical 
problems
Total animals 
named
10.93 ± 
5.84
10.50 (10.00) 0 – 24 3 (2.6%) N/A
Tower of London 112 (92.6%) 3 unable to 
complete 
6 technical 
problems
Total scorea 7.45 ± 
2.90
8.00 (2.00) 0 – 10 6 (5.4%) 26 (23.2%)
ACTB – cats and 
frogs 
86 (71.1%) 4 refused 
3 unable to 
complete 
28 technical 
problems
Stage 1 (cat 
rule alone) 
percentage 
correcta 
90.31 ± 
18.57
100.00 (9.32) 33.33 
– 100.00
0 (0.0%) 59 (68.6%)
Stage 2 (frog 
rule alone) 
percentage 
correcta 
79.83 ± 
27.12
95.83 (33.33) 0.00 
– 100.00
2 (2.3%) 43 (50.0%)
Stage 3 
(combined rules) 
percentage 
correcta 
66.96 ± 
21.64
56.16 (44.02) 33.33 
– 100.00
0 (0.0%) 13 (15.1%)
Finger-nose 
pointing 
116 (95.9%) 3 refused 
2 technical 
problems
Total completed 11.01 ± 
5.19
10.50 (8.00) 0 – 24 1 (0.9%) N/A
NEPSY-II 
– visuomotor 
precision 
118 (97.5%) 3 technical 
problems
Train and cara 15.90 ± 
5.26
18.00 (5.00) 2 – 23 0 (0.0%) 0 (0.0%)
Car and 
motorbikea 
17.00 ± 
9.61
18.00 (16.00) 0 – 40 1 (0.8%) 0 (0.0%)
ACTB – finger 
sequencing 
83 (68.6%) 3 refused 
10 unable to 
complete 
25 technical 
problems
Total complete 
sequences
231.42 
± 62.36
241.00 
(75.00)
30 – 369 0 (0.0%) N/A
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Table 7. Summary of results from informant questionnaires for adults aged 16–35. a Significantly deviated from 
normality using Shapiro-Wilk test (P<0.010), b higher scores indicate poorer abilities.
Questionnaire Outcome 
measure
Number 
completed
Mean ± SD Median (IQR) Range Number 
at floor
Number at 
ceiling
Short ABS Total scorea 118 (95.2%) 79.03 ± 19.73 84.00 (28.50) 28 – 112 0 (0.0%) 0 (0.0%)
Personal self-
sufficiencya
119 (96.0%) 28.91 ± 4.55 30.00 (6.00) 14 – 33 0 (0.0%) 31 (26.1%)
Community self-
sufficiency
119 (96.0%) 27.74 ± 10.36 29.00 (15.00) 4 – 47 0 (0.0%) 0 (0.0%)
Personal-social 
responsibilitya
119 (96.0%) 22.53 ± 6.49 23.00 (10.00) 7 – 32 0 (0.0%) 5 (4.2%)
DLDb Sum of cognitive 
scorea
114 (91.9%) 7.57 ± 8.40 4.00 (11.00) 0 – 39 0 (0.0%) 23 (20.2%)
Sum of social 
scoresa
118 (95.2%) 9.32 ± 6.85 8.50 (8.00) 0 – 31 0 (0.0%) 9 (7.6%)
OMQb Total score 119 (96.0%) 74.82 ± 18.43 75.00 (23.00) 33 – 120 0 (0.0%) 0 (0.0%)
BRIEF-Ab Total score 113 (91.1%) 121.03 ± 26.27 121.00 (31.00) 71 – 191 0 (0.0%) 0 (0.0%)
Behavioural 
regulation indexa
117 (94.4%) 50.75 ± 12.32 49.00 (17.00) 31 – 82 0 (0.0%) 0 (0.0%)
Metacognition 
index
113 (91.1%) 70.55 ± 16.71 70.00 (18.00) 40 – 116 0 (0.0%) 2 (1.8%)
Table 8. Comparing cognitive test scores between males and females for adults aged 16–35. All group comparisons 
used Mann Whitney U tests aside from a when Student’s t-tests were used as data did not deviate from normality.
Mean ± SD Median (IQR)
Males Females Males Females p
KBIT-2 verbal scorea 31.75 ± 13.68 38.20 ± 18.87 32.00 (16.00) 38.00 (28.00) 0.034
KBIT-2 non-verbal score 14.97 ± 6.90 15.00 ± 6.95 16.00 (7.00) 16.00 (7.00) 0.845
PAL first trial memory score 10.04 ± 5.17 10.39 ± 6.12 10.00 (7.00) 12.50 (11.00) 0.444
PAL levels completed 6.35 ± 2.37 6.23 ± 2.63 7.50 (2.00) 8.00 (3.50) 0.806
CAMCOG object naming 5.75 ± 0.61 5.74 ± 0.75 6.00 (0.00) 6.00 (0.00) 0.702
CAMCOG object recall 1.11 ± 1.34 1.26 ± 1.49 1.00 (2.00) 1.00 (2.00) 0.657
CAMCOG object recognition 4.07 ± 1.72 4.51 ± 1.45 4.50 (4.00) 5.00 (2.00) 0.207
CAMCOG orientation 9.18 ± 3.59 10.10 ± 3.29 11.00 (6.00) 12.00 (3.00) 0.086
Object memory immediate 10.30 ± 2.48 10.39 ± 3.15 11.00 (3.00) 11.00 (2.00) 0.367
Object memory delayed 5.91 ± 1.15 5.79 ± 1.65 6.00 (2.00) 6.00 (2.00) 0.664
Memory for sentences 29.16 ± 13.33 31.80 ± 14.00 33.00 (22.00) 34.00 (24.00) 0.267
IED errors stage 1 3.62 ± 6.12 4.72 ± 8.01 1.50 (3.00) 2.00 (3.00) 0.874
IED levels complete 6.88 ± 2.28 6.28 ± 2.74 7.00 (1.00) 7.00 (0.50) 0.212
SRT total correct 92.53 ± 15.24 93.12 ± 11.13 98.00 (8.50) 98.00 (7.50) 0.478
SRT mean latency (ms) 708.70 ± 517.62 675.95 ± 354.58 491.76 (485.52) 590.04 (442.00) 0.497
SRT latency standard deviation (ms) 293.94 ± 199.77 338.34 ± 216.53 244.95 (300.57) 319.94 (300.64) 0.290
CAMCOG verbal fluencya 10.52 ± 6.02 11.33 ± 5.68 10.00 (10.00) 12.00 (8.00) 0.462
Tower of London 7.64 ± 2.70 7.27 ± 3.08 8.00 (2.00) 9.00 (3.00) 0.879
Cats and frogs Stage 1 87.60 ± 21.42 92.89 ± 15.18 100.00 (18.18) 100.00 (8.33) 0.284
Cats and frogs Stage 2 80.36 ± 27.45 79.33 ± 27.11 91.67 (33.33) 100.00 (41.25) 0.952
Cats and frogs Stage 3 65.49 ± 20.03 68.37 ± 23.22 54.86 (35.79) 59.43 (48.00) 0.497
Finger nose pointinga 10.88 ± 5.48 11.14 ± 4.94 11.00 (8.00) 10.00 (8.00) 0.790
NEPSY-II visuomotor precision 
train and car
15.83 ± 4.97 15.97 ± 5.57 18.00 (5.00) 18.00 (5.00) 0.528
NEPSY-II visuomotor precision car 
and motorbikea
17.38 ± 9.83 16.63 ± 9.46 18.00 (17.00) 18.00 (15.00) 0.675
Finger sequencinga 238.08 ± 65.57 225.23 ± 59.31 250.50 (80.25) 241.00 (68.00) 0.352
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Table 9. Comparing informant scores between males and females for adults aged 16–35. All group 
comparisons used Mann Whitney U tests aside from a when Student’s t-tests were used as data did not 
deviate from normality.
Mean ± SD Median (IQR)
Males Females Males Females p
Short ABS Total score 77.69 ± 20.34 80.17 ± 19.29 79.50 (35.25) 84.50 (22.00) 0.563
Short ABS Personal 
self-sufficiency
28.95 ± 4.66 28.88 ± 4.48 31.00 (7.00) 30.00 (4.00) 0.704
Short ABS Community 
self-sufficiencya
27.24 ± 10.24 28.17 ± 10.53 27.00 (17.00) 30.00 (14.50) 0.625
Short ABS Personal-
social responsibility
21.84 ± 7.01 23.13 ± 5.99 22.00 (12.00) 25.00 (7.00) 0.384
DLD Sum of cognitive 
score
9.00 ± 8.74 6.28 ± 7.95 5.00 (14.00) 3.00 (8.75) 0.041
DLD Sum of social 
scores
9.16 ± 6.50 9.47 ± 7.20 8.50 (8.00) 8.50 (6.50) 0.985
OMQ Total scorea 77.93 ± 19.24 72.16 ± 17.42 79.00 (26.00) 71.50 (20.25) 0.089
BRIEF-A Total scorea 121.29 ± 28.01 120.81 ± 24.98 118.00 (41.00) 121.50 (24.25) 0.922
BRIEF-A Behavioural 
regulation indexa
50.83 ± 12.59 50.68 ± 12.19 49.00 (18.25) 49.00 (16.00) 0.948
BRIEF-A Metacognition 
indexa
71.33 ± 18.14 69.90 ± 15.56 71.00 (25.00) 70.00 (15.50) 0.653
Table 10. Correlations between cognitive test outcome scores and age across adults aged 16–35. Values given are correlation 
coefficients (p values); *p<0.05, **p<0.01, ***p<0.001. All correlations used were Spearman’s rho apart from a when Pearson’s correlation 
was used as data do not deviate from normality. Values in italics represent correlation coefficients greater than 0.50.
KBIT-2 
verbal 
score
KBIT-2 
non-
verbal 
score
PAL 
first trial 
memory 
score
Object 
memory 
immediate
Object 
memory 
delayed
Memory for 
sentences
Arena IED 
levels 
complete
SRT 
mean 
latency
SRT 
latency 
standard 
deviation
KBIT-2 verbal 
score
- 0.651*** 
(<0.001)
0.581*** 
(<0.001)
0.488*** 
(<0.001)
0.394*** 
(<0.001)
0.827*** 
(<0.001)
0.133 
(0.262)
0.409*** 
(<0.001)
-0.506*** 
(<0.001)
-0.583*** 
(<0.001)
KBIT-2 non-
verbal score
- - 0.636*** 
(<0.001)
0.448*** 
(<0.001)
0.460*** 
(<0.001)
0.510*** 
(<0.001)
0.243* 
(0.039)
0.387*** 
(<0.001)
-0.530*** 
(<0.001)
-0.533*** 
(<0.001)
PAL first 
trial memory 
score
- - - 0.522*** 
(<0.001)
0.450*** 
(<0.001)
0.467*** 
(<0.001)
0.171 
(0.157)
0.392*** 
(<0.001)
-0.489*** 
(<0.001)
-0.614*** 
(<0.001)
Object 
memory 
immediate
- - - - 0.536*** 
(<0.001)
0.342*** 
(<0.001)
0.043 
(0.728)
0.220* 
(0.027)
-0.358*** 
(<0.001)
-0.405*** 
(<0.001)
Object 
memory 
delayed
- - - - - 0.264** 
(0.008)
0.115 
(0.353)
0.174 
(0.083)
-0.238* 
(0.020)
-0.250* 
(0.014)
Memory for 
sentences
- - - - - - 0.172 
(0.155)
0.256* 
(0.011)
-0.387*** 
(<0.001)
-0.391*** 
(<0.001)
Arena - - - - - - - 0.108 
(0.371)
-0.265* 
(0.028)
-0.223 
(0.065)
IED levels 
complete
- - - - - - - - -0.288** 
(0.004)
-0.366*** 
(<0.001)
SRT mean 
latency
- - - - - - - - - 0.888*** 
(<0.001)
SRT latency 
standard 
deviation
- - - - - - - - - -
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Verbal 
fluency
Tower of 
London
Cats and 
frogs 
Stage 3
Finger 
nose 
pointing
NEPSY-II 
visuomotor 
precision 
train and 
car
NEPSY-II 
visuomotor 
precision 
car and 
motorbike
Finger 
sequencing
Age
KBIT-2 
verbal score
0.694*** 
(<0.001)a
0.429*** 
(<0.001)
0.568*** 
(<0.001)
0.592*** 
(<0.001)a
0.407*** 
(<0.001)
0.515*** 
(<0.001)
0.375*** 
(<0.001)a
0.040 
(0.662)
KBIT-2 non-
verbal score
0.503*** 
(<0.001)
0.380*** 
(<0.001)
0.541*** 
(<0.001)
0.563*** 
(<0.001)
0.323*** 
(<0.001)
0.502*** 
(<0.001)
0.490*** 
(<0.001)
-0.107 
(0.240)
PAL first 
trial memory 
score
0.442*** 
(<0.001)
0.522*** 
(<0.001)
0.495*** 
(<0.001)
0.584*** 
(<0.001)
0.468*** 
(<0.001)
0.539*** 
(<0.001)
0.334** 
(0.003)
-0.181 
(0.060)
Object 
memory 
immediate
0.430*** 
(<0.001)
0.261** 
(0.008)
0.277* 
(0.012)
0.385*** 
(<0.001)
0.207* 
(0.032)
0.380*** 
(<0.001)
0.250* 
(0.027)
0.038 
(0.692)
Object 
memory 
delayed
0.281** 
(0.003)
0.298** 
(0.002)
0.302** 
(0.006)
0.291** 
(0.002)
0.341*** 
(<0.001)
0.428*** 
(<0.001)
0.121 (0.293) 0.002 
(0.980)
Memory for 
sentences
0.593*** 
(<0.001)
0.229* 
(0.022)
0.482*** 
(<0.001)
0.373*** 
(<0.001)
0.226* 
(0.020)
0.334*** 
(<0.001)
0.334** 
(0.002)
-0.089 
(0.360)
Arena 0.149 
(0.214)
-0.047 
(0.699)
0.066 
(0.598)
0.126 
(0.288)
-0.010 
(0.934)
0.075 (0.526) 0.284* 
(0.017)
-0.005 
(0.968)
IED levels 
complete
0.372*** 
(<0.001)
0.302** 
(0.002)
0.305** 
(0.006)
0.406*** 
(<0.001)
0.241* 
(0.012)
0.286** 
(0.003)
0.194 (0.085) -0.048 
(0.621)
SRT mean 
latency
-0.426*** 
(<0.001)
-0.271** 
(0.006)
-0.406*** 
(<0.001)
-0.539*** 
(<0.001)
-0.296** 
(0.002)
-0.402*** 
(<0.001)
-0.628*** 
(<0.001)
0.115 
(0.239)
SRT latency 
standard 
deviation
-0.472*** 
(<0.001)
-0.433*** 
(<0.001)
-0.485*** 
(<0.001)
-0.572*** 
(<0.001)
-0.320** 
(0.001)
-0.438*** 
(<0.001)
-0.608*** 
(<0.001)
0.036 
(0.714)
Verbal 
fluency
- 0.331*** 
(<0.001)
0.391*** 
(<0.001)
0.600*** 
(<0.001)a
0.461*** 
(<0.001)
0.476*** 
(<0.001)
0.428*** 
(<0.001)a
-0.059 
(0.529)
Tower of 
London
- - 0.235* 
(0.034)
0.389*** 
(<0.001)
0.410*** 
(<0.001)
0.505*** 
(<0.001)
0.343** 
(0.002)
-0.024 
(0.797)
Cats and 
frogs Stage 
3
- - - 0.379*** 
(<0.001)
0.311** 
(0.004)
0.360** 
(0.001)
0.252* 
(0.030)
0.029 
(0.792)
Finger nose 
pointing
- - - - 0.530*** 
(<0.001)
0.524*** 
(<0.001)
0.586*** 
(<0.001)a
-0.083 
(0.373)
NEPSY-II 
visuomotor 
precision 
train and car
- - - - - 0.701*** 
(<0.001)
0.383*** 
(<0.001)
-0.043 
(0.637)
NEPSY-II 
visuomotor 
precision 
car and 
motorbike
- - - - - - 0.376*** 
(<0.001)
-0.014 
(0.877)
Finger 
sequencing
- - - - - - - -0.061 
(0.583)
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Table 11. Correlations between cognitive test outcome scores and age across adults aged 16–35. Values given are correlation 
coefficients (p values); *p<0.05, **p<0.01, ***p<0.001. All correlations used were Spearman’s rho apart from a when Pearson’s 
correlation was used as data do not deviate from normality. Values in italics represent correlation coefficients greater than 0.50.
Short ABS 
Personal 
self-
sufficiency
Short ABS 
Community self-
sufficiency
Short ABS 
Personal-social 
responsibility
OMQ 
Total 
score
BRIEF-A 
Behavioural 
regulation 
index
BRIEF-A 
Metacognition 
index
Age
Short ABS 
Personal self-
sufficiency
- 0.719*** (<0.001) 0.687*** (<0.001) -0.426*** 
(<0.001)
-0.380*** 
(<0.001)
-0.549*** (<0.001) 0.111 
(0.230)
Short ABS 
Community self-
sufficiency
- - 0.762*** (<0.001) -0.535*** 
(<0.001)a
-0.457*** 
(<0.001)
-0.669*** (<0.001)a 0.162 
(0.077)
Short ABS 
Personal-social 
responsibility
- - - -0.631*** 
(<0.001)
-0.572*** 
(<0.001)
-0.731*** (<0.001) 0.087 
(0.346)
OMQ Total score - - - - 0.488*** 
(<0.001)
0.741*** (<0.001)a -0.122 
(0.187)
BRIEF-A 
Behavioural 
regulation index
- - - - - 0.643*** (<0.001) 0.070 
(0.452)
BRIEF-A 
Metacognition 
index
- - - - - - -0.125 
(0.187)
Non-verbal age-adjusted IQ scores had lower floor effects than 
verbal IQ scores for all groups.
Females aged 16–35 years performed better than males on 
general verbal abilities, and also showed better cognitive abilities 
as assessed by the DLD cognitive domain. We identified clusters 
of cognitive test scores within our battery relating to visuospatial 
memory, motor coordination, language abilities, and processing 
speed / sustained attention.
Our results show a wide range of individuals’ cognitive abilities, 
and suggest our battery is suitable for a wide range of adults with 
DS. Our future studies will use our baseline results presented here 
to investigate cognitive abilities and changes in cognitive abili-
ties associated with ageing and dementia. Individual differences 
in the dementia phenotype and cognitive profiles of people with 
DS emphasises the importance of studying factors contributing 
towards these variations (Karmiloff-Smith et al., 2016). We will 
also investigate factors including genetic, medical and socioeco-
nomic variations that may be associated with these abilities. We 
hope our results will help identify risk and protective factors for 
the development of dementia in people with DS, and factors relat-
ing to baseline cognitive abilities. This will aid identifying relevant 
potential mechanisms and predictive phenotypes, and may help to 
inform interventions that can influence developmental trajectories.
Final test and outcome selection
Many of the tests within our battery show a range of scores with 
low floor and ceiling effects and high validity, as determined by 
exploring relationships between outcomes in Cohort 2. However, 
several tests within our battery may have limited use based on our 
study aims. Firstly, the CAMCOG incidental memory test may not 
be useful, with high floor effects for the recall score for all groups. 
Future longitudinal studies will determine if this is a useful test to 
assess cognitive decline within individuals. Secondly, a previous 
pilot study suggested the virtual generated arena is not useful in 
older adults (Sinai & Strydom, unpublished observations), and 
our current analyses showed that for younger adults the test scores 
showed limited correlations with other task measures. Further, 
both the mean and median times spent in the correct quadrant were 
approximately 25%, and as individuals should spend 25% of their 
time in the correct quadrant by chance alone this suggests this 
measure is not useful.
As expected, when converting raw scores on the KBIT-2 to 
age-dependent IQ scores we found high floor effects across all par-
ticipant groups. IQ score floor effects were lower for non-verbal 
IQ than verbal IQ in all our groups. Age-dependent non-verbal 
IQ scores may therefore be more useful than verbal IQ 
scores for future studies, and also offer an advantage if comparing 
individuals or studies across language groups.
The ideal test and outcome measure to use in neuropsychologi-
cal research depends upon the cognitive ability of interest, the 
specific research question and population assessed, in addition to 
floor/ceiling effects and the spread of results observed. Within 
different age cohorts and for our different research questions differ-
ent tests and outcome measures will therefore be useful, in particu-
lar as score ranges and floor and ceiling effects varied across groups 
(e.g. to assess cognitive decline then outcomes with low floor effects 
prior to the onset of decline are essential). For several cognitive 
tasks within our battery, in particular the CANTAB tasks, there are 
multiple outcome measures, and we have identified those outcomes 
that will be most useful in our future studies (see Box 1).
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Box 1. Ideal outcome measures to use in future studies
Test Outcome measure Comments
PAL First trial memory 
score
Ideal for younger adults as wide range with no ceiling 
effect
Number of stages 
complete
Ideal for older adults as small floor effect
IED Number of stages 
completed
Ideal for younger adults as can identify subgroups who 
can complete extra-dimensional shift and who cannot 
pass any levels
SRT Latency standard 
deviation
Ideal for older and younger adults to measure attention 
as no floor or ceiling effect and accounts for individual 
variations in motor coordination
Object memory Immediate memory 
score
Ideal for younger adults as small ceiling effect and 
wide range of scores
NEPSY-II visuomotor 
precision
Car and motorbike 
score
Ideal for older and younger adults as wide range
Cats and frogs Stage 3 Ideal for younger adults as small ceiling effect and can 
identify subgroup able to follow both rules
A high proportion of individuals with dementia were unable to 
complete any cognitive tests. For those able to undertake cogni-
tive tasks completion rates were generally higher for table-top tasks 
compared to computer tasks. This suggests the use of some longer 
computer tasks may not be suitable for an older population at risk 
for dementia, and instead may need to be replaced with traditional 
table-top tasks and informant questionnaires. We also noted that 
in many adults with dementia and in some adults aged 36+ years 
without dementia attention levels appeared to negatively affect 
task performance. A similar observation was made by Sinai et al. 
(2016), and future test batteries should account for this.
Finally, during data collection we found some questions within two 
of the informant questionnaires used, the BRIEF-A and OMQ, were 
often unsuitable for older adults and those with more severe IDs. As 
a result, we developed a new informant questionnaire, the Cognitive 
Scale for Down Syndrome (CS-DS), to assess cognitive abilities 
in people with DS, focusing on executive function, memory and 
language abilities. This questionnaire showed high reliability and 
validity (Startin et al., 2016a).
Validity of the test battery
The majority of cognitive test scores correlated well with all 
other cognitive test scores in adults aged 16–35. It has previously 
been proposed that cognitive measures are more highly correlated 
in those with lower compared to higher IQs (Detterman & Daniel, 
1989). The high correlations between test scores and KBIT-2 
raw scores indicate that higher general abilities are related 
to better individual task performance, and it has similarly 
been suggested the high variability in neurocognitive task 
performance in people with DS is due to variability in IQ (de Sola 
et al., 2015). Further, de Sola et al. (2015) and Liogier d’Ardhuy 
et al. (2015) found better task performance in individuals with 
higher IQs.
To determine clusters of related cognitive outcomes in adults 
aged 16–35 before the onset of cognitive decline we examined 
correlational coefficients of 0.50 and above. We identified the 
presence of clusters relating to visuospatial memory, motor coor-
dination, language abilities, and sustained attention/processing 
speed. These results suggest the presence of related cognitive 
abilities in this population that could inform further development 
of outcome measures.
Effect of sex on task performance
We found females scored higher for KBIT-2 verbal scores and for 
informant report for the DLD cognitive domain than males in adults 
aged 16–35 years. Previous studies have also reported higher lin-
guistic abilities in females compared to males (de Sola et al., 2015; 
Liogier d’Ardhuy et al., 2015), in addition to better performance 
on tasks of memory, executive function and attention (including the 
PAL and SRT) (de Sola et al., 2015) and higher functional abilities 
(Lund, 1988; Määttä et al., 2006). The effect of gender on cognitive 
and functional abilities in DS requires further study.
Possible effect of cognitive decline and ageing on task 
performance
We found no significant correlations with age and cognitive test 
outcomes or informant questionnaire scores in adults aged 16–35. 
Performance was however generally poorer in adults aged 36+ 
compared to those aged 16–35. Our future analyses will focus 
on the impact of cognitive decline and ageing on abilities in 
individuals with DS.
Previous studies have confirmed poorer performance on many of 
the cognitive tasks within our battery for adults with cognitive 
decline or dementia compared to those with no decline (Adams 
& Oliver, 2010; Ball et al., 2008; Oliver et al., 2005; Sinai et al., 
2016). Previous studies have also found poorer performance 
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associated with ageing in DS for the PAL (Crayton et al., 1998; 
Oliver et al., 2005) and Tower of London (Ghezzo et al., 2014). 
These results suggest our battery should be sensitive to the presence 
of dementia and many of our tasks may be useful for predicting 
and tracking cognitive decline. Cognitive abilities and changes in 
these individuals over the course of our longitudinal study will be of 
particular interest when determining the effects of age-related and 
dementia-related changes in cognition.
Strengths and limitations
A major strength of our study and analyses is the large sample size, 
including a wide variety of ages and ID severities, and both those 
with and without a clinical diagnosis of dementia. We recruited 
individuals from a variety of settings, including volunteers and local 
ID clinical teams, suggesting our sample should be representative 
of individuals with DS in the UK.
Our results suggest the majority of our tasks have high completion 
rates for adults who do not have a diagnosis of dementia, with test 
scores showing a wide range and select outcomes showing low floor 
and ceiling effects. The battery will therefore be largely suitable for 
further analyses to assess cognitive decline, dementia, ageing, and 
baseline cognitive abilities in adults with DS.
For adults with a diagnosis of dementia completion rates were 
much lower however, although this population will always be 
difficult to assess with psychometric tests. For adults unable to 
complete any of the tasks in the battery informant ratings of abili-
ties are invaluable, although further work is needed to determine 
the relationships between cognitive test scores and informant 
measure outcomes. A further limitation lies with the use of KBIT-2 
IQ scores, which showed a high number of individuals at floor level, 
similar to other IQ tests in this population. For this reason we chose 
to use raw scores as the main outcome for the KBIT-2.
Conclusion
We report a cognitive battery and related informant measures to 
assess general abilities, memory, executive function, and motor 
coordination abilities in individuals with DS. We assessed partici-
pants with a range of ages and abilities, and our results suggest the 
battery is suitable for the majority of adults with DS. Many test 
outcomes showed a range of scores with low floor and ceiling 
effects. This battery will be used in our future studies to assess 
factors influencing individual differences in cognitive decline, 
dementia, ageing, and baseline cognitive abilities in adults with DS.
Data availability
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 Bessy Benejam
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Down syndrome (DS) is associated with a very high risk of developing Alzheimer’s disease (AD).
Diagnosing dementia in individuals with DS can be difficult because of the challenges involved in
assessing changes in people with pre-existing cognitive impairment and due to a lack of appropriate
instruments. The authors study a very important topic, the search for an appropriate battery of tests
suitable for the assessment of cognitive functions of individuals with a wide range of ages and intellectual
disability (ID) severities, and for the early detection of cognitive decline associated to the development of
AD. Startin and colleagues describe the LonDownS cognitive test battery for adults with Down syndrome
(DS), and provide data on baseline cognitive and related informant assessments for two cohorts of
participants ( : adults aged 36 and over with or without clinical diagnosis of dementia;  :cohort 1 cohort 2
adults aged 16-35 years).
The authors found high completion rates across the tasks for individuals without dementia, with many
showing low floor and ceiling effects. Results from individuals with dementia suggest lower completion
rates (approximately half of the individuals with dementia were unable to undertake any task).
To my point of view, the manuscript is well written, hypothesis and methods are adequately described,
and it is overall well discussed.
 
I have some suggestions to improve the manuscript format and some questions that the authors could
clarify:
After reading the title of the manuscript, one expects to find some comparison in task performance
between individuals with and without dementia, with the aim to find cognitive tasks able to
discriminate well between both groups. I think the manuscript would benefit from the inclusion of a
new table with the main outcome measures and results from informant questionnaires for both
adults with and without dementia, with its statistical differences.
 
The conclusions of the study are well written and described, but I suggest reviewing the
“Conclusion” section of the Abstract because it does not explain what the current study found.
 
As stated in the “Methods” section (Task administration), the assessment was completed in
. Although this limitation isone session where possible, approximately 3 hours in duration
imposed by the study set up, this might represent a limitation worth mentioning. In my opinion, this
duration might be too long for people with intellectual disability, a population that might get tired
more easily and has usually difficulties with sustained attention. The validation study conducted by
Sinai and colleagues, which found very similar scores for a number of tests (some of them also
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more easily and has usually difficulties with sustained attention. The validation study conducted by
Sinai and colleagues, which found very similar scores for a number of tests (some of them also
used by Startin and colleagues) when comparing dementia and no dementia groups of older
people with DS, could help to reduce the length of the cognitive test battery.
 
The authors recruited 51 adults aged 36 years and over, with a clinical diagnosis of dementia. Of
these, 22 (43%) had a diagnosis of AD and 27 (more than 50%) had a diagnosis of dementia of
unspecified type. This is a surprising high figure for a population with an ultra-high risk for AD. The
manuscript does not describe who made the diagnosis of dementia or how it was made. It could
also be interesting to include some information about the stage of the dementia. Which patients
were unable to undertake the assessment? Was this related to a more advanced stage of
dementia, or was this related to a more severe premorbid intellectual disability?
 
The number of tables in the results section might be reduced. Some of them might be included if
deemed important as supplementary material. For example, given that there are few differences
between males and females, and the findings about the correlation between outcome scores for
Cohort 2 are well explained in the results section, I suggest Tables 8 to 11 could be included as
supplementary material.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
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 Alessandro Ghezzo
Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum-University of
Bologna, Bologna, Italy
The Authors describe their cognitive test battery to assess neuropsychological abilities in two groups of
adults with Down syndrome (DS) (a group of 16-35 years of age and another group aged 36 and over),
and related informant measures along with reporting data from their baseline cognitive and informant
assessments. The ultimate goal of this study is to put the basis for a longitudinal neuropsychological
evaluation of people with DS: The LonDownS Consortium, aimed at determining risk and protective
factors for the development of dementia and factors relating to cognitive abilities in people with DS.
The topic addressed by the authors is of great interest not only for people with DS. In fact, with the
increase in life expectancy and the resulting aging of the general population, age-related
neurodegenerative disorders, such as neurocognitive impairment, are expected to increase. DS is
considered a model of premature aging, and therefore the study of dementia in DS and the evaluation of
favouring or protective factors, can bring benefits both for people with DS and for general population. 
 A comprehensive assessment
The Authors performed a very comprehensive neuropsychological evaluation, to assess a range of
skills relevant to those brain areas most affected in DS, including general abilities, visuo-spatial
and verbal memory, language skills, executive functions and motor coordination abilities.
 
The effort to avoid floor and ceiling effects
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The effort to avoid floor and ceiling effects
The Authors show not only the results and the related statistical analysis, but also the reasoning
why they have chosen that specific test and the scientific background: in my opinion this issue is of
great interest, because the neuropsychological evaluation of people with intellectual disability (ID)
is a relatively young discipline, and there is a great effort worldwide aimed to identify a test battery
specifically suitable for people with ID. 
In fact, the main problem in the assessment of people with DS, and more generally of people with
ID, is that most of the neuropsychological tests were conceived and designed for cognitive
evaluation of people without ID. The consequence of this is that often they cannot be used in
people with ID, because of the floor and ceiling effects. In both cases, they do not give indications
for neuropsychological assessment and for longitudinal studies. The effort of the authors was to
identify a set of tests that present minimum percentages of floor and ceiling effects, in order to
make them suitable for the neuropsychological assessment of people with DS.
According to the results this effort has been successful: in this study most of the persons with DS
without dementia were able to perform the tests and the percentage of floor and ceiling effect was
very low (except for CAMCOG – delayed incidental memory and KBIT-2 age-dependent IQ
scores).
 
Administration times
Another important parameter is given by the administration times. The authors specify that the test
administration, most often conducted in the person's home, lasted overall about three hours,
including breaks necessary to rest and, wherever possible, physical measurements (height,
weight, abdominal/ head/neck circumference, gait, blood pressure, and pulse). In my opinion it is a
perfectly acceptable time for such a comprehensive assessment, also in the light of possible
follow-up in order to detect early symptoms of cognitive decline.
Some questions and suggestions
Question 1: Have the Authors performed a correlation between cognitive scores and informant scores?
Question 2: Have the Authors performed a correlation between age and cognitive/informant scores
considering the whole group of persons with DS (16-35 years of age + aged 36 and over)  
Question 3: Which informant questionnaire can be suggested by the Authors to be used in association
with the tests listed in Box1 (Ideal outcome measures to use in future studies)?
Suggestion: I think that the title of Table 11 is wrong and should be changed in “Correlations between
informant scores and age across adults aged 16–35”
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
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